Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immediate-Early Proteins | 13 | 2018 | 449 | 3.870 |
Why?
|
Lasers | 11 | 2021 | 951 | 2.470 |
Why?
|
Adjuvants, Immunologic | 9 | 2021 | 1036 | 1.970 |
Why?
|
Vaccination | 9 | 2021 | 3381 | 1.680 |
Why?
|
Skin | 16 | 2021 | 4481 | 1.610 |
Why?
|
Desensitization, Immunologic | 3 | 2021 | 545 | 1.330 |
Why?
|
Influenza Vaccines | 4 | 2020 | 767 | 1.290 |
Why?
|
Vaccines | 5 | 2014 | 837 | 0.990 |
Why?
|
Malaria Vaccines | 2 | 2016 | 165 | 0.910 |
Why?
|
Allergens | 3 | 2021 | 1410 | 0.910 |
Why?
|
Ubiquinone | 2 | 2016 | 183 | 0.890 |
Why?
|
Thrombocytopenia | 3 | 2016 | 1179 | 0.890 |
Why?
|
Phototherapy | 2 | 2017 | 368 | 0.880 |
Why?
|
Genes, Immediate-Early | 2 | 2014 | 102 | 0.860 |
Why?
|
Mice, Inbred BALB C | 14 | 2020 | 6215 | 0.840 |
Why?
|
Needles | 5 | 2019 | 451 | 0.810 |
Why?
|
Blood Platelets | 5 | 2019 | 2481 | 0.780 |
Why?
|
Thymol | 1 | 2021 | 2 | 0.770 |
Why?
|
Aminolevulinic Acid | 1 | 2022 | 144 | 0.760 |
Why?
|
Myoblasts | 1 | 2021 | 231 | 0.720 |
Why?
|
Powders | 6 | 2021 | 80 | 0.700 |
Why?
|
Porphyrins | 1 | 2022 | 352 | 0.700 |
Why?
|
Administration, Cutaneous | 7 | 2019 | 713 | 0.680 |
Why?
|
Microinjections | 3 | 2017 | 321 | 0.680 |
Why?
|
Acinetobacter baumannii | 1 | 2021 | 118 | 0.670 |
Why?
|
Pulmonary Surfactants | 1 | 2020 | 162 | 0.660 |
Why?
|
Mice | 41 | 2022 | 81509 | 0.660 |
Why?
|
Influenza A Virus, H5N1 Subtype | 2 | 2020 | 113 | 0.660 |
Why?
|
Nucleotides, Cyclic | 1 | 2020 | 84 | 0.660 |
Why?
|
Thrombopoiesis | 3 | 2016 | 165 | 0.650 |
Why?
|
Pseudomonas aeruginosa | 3 | 2022 | 1277 | 0.650 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 2225 | 0.620 |
Why?
|
Infrared Rays | 2 | 2020 | 247 | 0.620 |
Why?
|
Biomimetic Materials | 1 | 2020 | 172 | 0.610 |
Why?
|
Sporozoites | 2 | 2016 | 82 | 0.610 |
Why?
|
Injections, Intradermal | 5 | 2017 | 116 | 0.600 |
Why?
|
Orthomyxoviridae Infections | 2 | 2020 | 254 | 0.600 |
Why?
|
Animals | 51 | 2022 | 168441 | 0.590 |
Why?
|
Megakaryocytes | 3 | 2016 | 566 | 0.590 |
Why?
|
Reticulocytes | 1 | 2018 | 289 | 0.580 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 697 | 0.580 |
Why?
|
Mitochondria | 6 | 2018 | 3623 | 0.570 |
Why?
|
Th17 Cells | 3 | 2012 | 794 | 0.550 |
Why?
|
Laser Therapy | 3 | 2014 | 1092 | 0.550 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 291 | 0.550 |
Why?
|
Peanut Hypersensitivity | 1 | 2019 | 214 | 0.540 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 623 | 0.540 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 4 | 2012 | 34 | 0.540 |
Why?
|
Reactive Oxygen Species | 5 | 2022 | 2141 | 0.540 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2020 | 445 | 0.530 |
Why?
|
Transdermal Patch | 1 | 2016 | 51 | 0.530 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2013 | 1135 | 0.530 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2007 | 89 | 0.520 |
Why?
|
Myelodysplastic Syndromes | 2 | 2018 | 1394 | 0.520 |
Why?
|
Mice, Inbred C57BL | 18 | 2020 | 22163 | 0.510 |
Why?
|
Mice, Knockout | 15 | 2018 | 14409 | 0.500 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2016 | 101 | 0.500 |
Why?
|
Capillary Permeability | 2 | 2016 | 774 | 0.500 |
Why?
|
Apoptosis | 8 | 2018 | 9488 | 0.490 |
Why?
|
Insect Bites and Stings | 1 | 2015 | 71 | 0.470 |
Why?
|
Cell Differentiation | 4 | 2021 | 11526 | 0.470 |
Why?
|
Erythropoiesis | 1 | 2018 | 682 | 0.470 |
Why?
|
Pyruvic Acid | 1 | 2015 | 204 | 0.460 |
Why?
|
BCG Vaccine | 1 | 2017 | 369 | 0.460 |
Why?
|
Colitis | 3 | 2012 | 1233 | 0.460 |
Why?
|
Light | 2 | 2022 | 1352 | 0.450 |
Why?
|
Antigen-Presenting Cells | 3 | 2015 | 965 | 0.450 |
Why?
|
Fetal Blood | 1 | 2020 | 1347 | 0.450 |
Why?
|
Bacterial Infections | 1 | 2022 | 1393 | 0.450 |
Why?
|
Biosensing Techniques | 1 | 2019 | 649 | 0.440 |
Why?
|
Organophosphorus Compounds | 1 | 2014 | 206 | 0.430 |
Why?
|
Head Injuries, Closed | 1 | 2014 | 133 | 0.430 |
Why?
|
Food Hypersensitivity | 1 | 2021 | 708 | 0.430 |
Why?
|
Adipose Tissue, White | 1 | 2016 | 365 | 0.430 |
Why?
|
Immune Tolerance | 2 | 2021 | 2300 | 0.430 |
Why?
|
Escherichia coli | 2 | 2022 | 4218 | 0.420 |
Why?
|
Brain Injuries | 2 | 2015 | 2053 | 0.420 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1458 | 0.420 |
Why?
|
Biofilms | 3 | 2022 | 627 | 0.410 |
Why?
|
Encephalitis | 1 | 2016 | 438 | 0.410 |
Why?
|
Anti-Infective Agents | 1 | 2019 | 982 | 0.400 |
Why?
|
Metabolic Diseases | 1 | 2018 | 681 | 0.390 |
Why?
|
Lymphocytes | 2 | 2017 | 2611 | 0.390 |
Why?
|
Nanoparticles | 2 | 2020 | 1955 | 0.370 |
Why?
|
Benzoquinones | 2 | 2022 | 198 | 0.370 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2019 | 295 | 0.370 |
Why?
|
Cell Survival | 5 | 2019 | 5790 | 0.370 |
Why?
|
Adipose Tissue, Brown | 1 | 2016 | 764 | 0.350 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 291 | 0.350 |
Why?
|
Graft Survival | 1 | 2020 | 3819 | 0.340 |
Why?
|
Lactic Acid | 1 | 2015 | 1137 | 0.340 |
Why?
|
Mice, Mutant Strains | 3 | 2020 | 1750 | 0.340 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4575 | 0.340 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2016 | 1116 | 0.330 |
Why?
|
Psoriasis | 1 | 2017 | 939 | 0.330 |
Why?
|
Injections, Subcutaneous | 3 | 2021 | 680 | 0.320 |
Why?
|
Diabetes Complications | 1 | 2016 | 1315 | 0.320 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 560 | 0.310 |
Why?
|
Hydrocortisone | 1 | 2016 | 1815 | 0.310 |
Why?
|
Ovalbumin | 3 | 2016 | 677 | 0.310 |
Why?
|
Dendritic Cells | 3 | 2018 | 2746 | 0.310 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2009 | 136 | 0.300 |
Why?
|
Antigens, CD | 1 | 2018 | 4001 | 0.290 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2008 | 102 | 0.290 |
Why?
|
Nicotine | 1 | 2012 | 680 | 0.290 |
Why?
|
Membrane Proteins | 5 | 2020 | 7856 | 0.290 |
Why?
|
Immunization | 1 | 2012 | 1227 | 0.290 |
Why?
|
Mammals | 2 | 2022 | 1132 | 0.270 |
Why?
|
Colon | 2 | 2012 | 1792 | 0.270 |
Why?
|
Cyclic AMP | 1 | 2010 | 1463 | 0.270 |
Why?
|
Th1 Cells | 1 | 2011 | 1037 | 0.260 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.260 |
Why?
|
Cell Movement | 3 | 2016 | 5203 | 0.260 |
Why?
|
Rhodamines | 3 | 2017 | 178 | 0.240 |
Why?
|
Influenza, Human | 1 | 2016 | 1521 | 0.240 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1784 | 0.240 |
Why?
|
Wound Healing | 1 | 2016 | 2803 | 0.240 |
Why?
|
Hematopoiesis | 1 | 2013 | 2049 | 0.230 |
Why?
|
Chemokines | 1 | 2008 | 959 | 0.230 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1491 | 0.230 |
Why?
|
Receptors, Chemokine | 1 | 2007 | 652 | 0.220 |
Why?
|
Cytokines | 5 | 2017 | 7392 | 0.220 |
Why?
|
Sus scrofa | 2 | 2015 | 428 | 0.220 |
Why?
|
Hippocampus | 1 | 2015 | 3763 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5670 | 0.200 |
Why?
|
T-Lymphocyte Subsets | 2 | 2012 | 1806 | 0.200 |
Why?
|
Plankton | 1 | 2021 | 21 | 0.190 |
Why?
|
Superoxides | 2 | 2014 | 386 | 0.190 |
Why?
|
Swine | 3 | 2016 | 5914 | 0.180 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3396 | 0.180 |
Why?
|
Sphingosine | 2 | 2016 | 308 | 0.180 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2017 | 398 | 0.180 |
Why?
|
Mice, SCID | 2 | 2020 | 2626 | 0.180 |
Why?
|
Lysophospholipids | 2 | 2016 | 338 | 0.180 |
Why?
|
Klebsiella pneumoniae | 1 | 2022 | 250 | 0.180 |
Why?
|
Colonic Neoplasms | 1 | 2012 | 2538 | 0.170 |
Why?
|
Immunoglobulin G | 3 | 2017 | 4549 | 0.170 |
Why?
|
Caspase 3 | 2 | 2016 | 731 | 0.170 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2020 | 83 | 0.170 |
Why?
|
Ferrets | 1 | 2020 | 177 | 0.170 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3702 | 0.160 |
Why?
|
Decontamination | 1 | 2019 | 72 | 0.160 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7409 | 0.160 |
Why?
|
Blood Preservation | 1 | 2019 | 168 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2021 | 542 | 0.150 |
Why?
|
Administration, Intranasal | 1 | 2020 | 477 | 0.150 |
Why?
|
Adoptive Transfer | 3 | 2011 | 819 | 0.150 |
Why?
|
Neoplasm Proteins | 2 | 2002 | 3612 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 312 | 0.150 |
Why?
|
Signal Transduction | 3 | 2012 | 23441 | 0.150 |
Why?
|
Immunity, Innate | 1 | 2009 | 3061 | 0.140 |
Why?
|
Ultraviolet Therapy | 1 | 2017 | 84 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1960 | 0.140 |
Why?
|
Nail Diseases | 1 | 2017 | 55 | 0.140 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2018 | 241 | 0.140 |
Why?
|
Rolipram | 1 | 2016 | 24 | 0.140 |
Why?
|
Lymphocyte Activation | 2 | 2012 | 5490 | 0.140 |
Why?
|
Microscopy, Confocal | 2 | 2015 | 1970 | 0.140 |
Why?
|
Skin Absorption | 1 | 2017 | 94 | 0.140 |
Why?
|
Protein Engineering | 1 | 2020 | 549 | 0.140 |
Why?
|
Gold | 1 | 2020 | 478 | 0.140 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2021 | 587 | 0.130 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2016 | 34 | 0.130 |
Why?
|
Calorimetry | 1 | 2016 | 129 | 0.130 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 396 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.130 |
Why?
|
Liposomes | 1 | 2020 | 783 | 0.130 |
Why?
|
Immunity | 2 | 2015 | 997 | 0.130 |
Why?
|
Titanium | 1 | 2018 | 484 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4370 | 0.130 |
Why?
|
Cells, Cultured | 4 | 2016 | 18964 | 0.130 |
Why?
|
Graft vs Host Disease | 1 | 2008 | 3030 | 0.130 |
Why?
|
Microtechnology | 1 | 2016 | 70 | 0.130 |
Why?
|
Cross Protection | 1 | 2015 | 25 | 0.120 |
Why?
|
Plasmodium yoelii | 1 | 2015 | 42 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4575 | 0.120 |
Why?
|
Interferon Inducers | 1 | 2014 | 25 | 0.120 |
Why?
|
Humans | 21 | 2021 | 761423 | 0.120 |
Why?
|
Calcitriol | 1 | 2016 | 296 | 0.120 |
Why?
|
Interferon Regulatory Factor-7 | 1 | 2014 | 36 | 0.120 |
Why?
|
Squalene | 1 | 2014 | 35 | 0.120 |
Why?
|
Respiratory Hypersensitivity | 1 | 2016 | 273 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 832 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1937 | 0.120 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 779 | 0.120 |
Why?
|
Aminoquinolines | 1 | 2014 | 107 | 0.120 |
Why?
|
Antigens, CD34 | 1 | 2016 | 658 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2498 | 0.110 |
Why?
|
Platelet Count | 1 | 2016 | 782 | 0.110 |
Why?
|
Epidermis | 1 | 2017 | 527 | 0.110 |
Why?
|
Administration, Topical | 1 | 2016 | 703 | 0.110 |
Why?
|
Vaccines, Attenuated | 1 | 2015 | 315 | 0.110 |
Why?
|
Obesity | 1 | 2016 | 12938 | 0.110 |
Why?
|
Flow Cytometry | 2 | 2016 | 5868 | 0.110 |
Why?
|
Whole-Body Irradiation | 1 | 2014 | 433 | 0.110 |
Why?
|
Immunologic Memory | 1 | 2020 | 1358 | 0.110 |
Why?
|
Interferon-gamma | 2 | 2012 | 3159 | 0.110 |
Why?
|
Diabetic Neuropathies | 1 | 2016 | 405 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1179 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2016 | 3466 | 0.100 |
Why?
|
Phagocytosis | 1 | 2018 | 1536 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15498 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4510 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2015 | 656 | 0.100 |
Why?
|
Edema | 1 | 2016 | 767 | 0.100 |
Why?
|
Azoxymethane | 1 | 2012 | 35 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2016 | 18247 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1989 | 0.100 |
Why?
|
Dermatitis | 1 | 2014 | 201 | 0.100 |
Why?
|
Macrophages | 2 | 2018 | 5768 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 606 | 0.100 |
Why?
|
Thermogenesis | 1 | 2016 | 475 | 0.100 |
Why?
|
Methylene Blue | 1 | 2012 | 155 | 0.100 |
Why?
|
Gene Expression | 2 | 2016 | 7584 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 371 | 0.090 |
Why?
|
Dextran Sulfate | 1 | 2012 | 256 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2016 | 1870 | 0.090 |
Why?
|
Antibodies | 3 | 2017 | 2421 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2017 | 1469 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2014 | 916 | 0.090 |
Why?
|
Spleen | 1 | 2017 | 2295 | 0.090 |
Why?
|
Rotenone | 1 | 2010 | 45 | 0.090 |
Why?
|
Male | 14 | 2017 | 360736 | 0.090 |
Why?
|
Metalloporphyrins | 1 | 2010 | 41 | 0.090 |
Why?
|
Pertussis Toxin | 1 | 2010 | 176 | 0.090 |
Why?
|
Injury Severity Score | 1 | 2014 | 1045 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1326 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17912 | 0.090 |
Why?
|
Neuralgia | 1 | 2016 | 614 | 0.090 |
Why?
|
Leishmania major | 1 | 2009 | 59 | 0.080 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1495 | 0.080 |
Why?
|
Bacteria | 1 | 2021 | 2199 | 0.080 |
Why?
|
Analgesics | 1 | 2016 | 1070 | 0.080 |
Why?
|
NF-kappa B | 1 | 1998 | 2488 | 0.080 |
Why?
|
Fatty Liver | 1 | 2016 | 789 | 0.080 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 211 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2248 | 0.080 |
Why?
|
Female | 12 | 2017 | 392581 | 0.080 |
Why?
|
Sirolimus | 1 | 2016 | 1533 | 0.080 |
Why?
|
Transfection | 2 | 2012 | 5775 | 0.080 |
Why?
|
Spinal Cord Injuries | 1 | 2016 | 925 | 0.080 |
Why?
|
Neoplasms, Experimental | 2 | 2018 | 1230 | 0.080 |
Why?
|
Pharmaceutical Preparations | 1 | 2017 | 1088 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2028 | 0.080 |
Why?
|
Lung | 2 | 2017 | 9995 | 0.070 |
Why?
|
Intestinal Mucosa | 2 | 2012 | 3030 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2017 | 1903 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2011 | 657 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1762 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2014 | 1474 | 0.070 |
Why?
|
Chemokine CXCL11 | 1 | 2007 | 43 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2011 | 1084 | 0.070 |
Why?
|
Chemokine CXCL9 | 1 | 2007 | 135 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 703 | 0.070 |
Why?
|
Neoplasms | 2 | 2013 | 22164 | 0.070 |
Why?
|
Lymphoid Tissue | 1 | 2008 | 445 | 0.070 |
Why?
|
Immunotherapy | 2 | 2012 | 4650 | 0.070 |
Why?
|
Autoantibodies | 1 | 2015 | 2124 | 0.070 |
Why?
|
Phenotype | 2 | 2016 | 16606 | 0.070 |
Why?
|
Antioxidants | 1 | 2014 | 1669 | 0.070 |
Why?
|
Vasodilation | 1 | 2010 | 961 | 0.070 |
Why?
|
DNA Primers | 1 | 2010 | 2820 | 0.070 |
Why?
|
Antigens | 1 | 2012 | 1446 | 0.070 |
Why?
|
Nuclear Localization Signals | 1 | 2006 | 77 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 696 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2065 | 0.060 |
Why?
|
Biological Transport, Active | 1 | 2006 | 328 | 0.060 |
Why?
|
Receptors, CXCR3 | 1 | 2007 | 238 | 0.060 |
Why?
|
Chemokine CXCL10 | 1 | 2007 | 316 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2695 | 0.060 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2005 | 64 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 663 | 0.060 |
Why?
|
T-Lymphocytes | 3 | 2011 | 10194 | 0.060 |
Why?
|
Cell Lineage | 1 | 2014 | 2555 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2012 | 9535 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 422 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2011 | 911 | 0.060 |
Why?
|
Smad2 Protein | 1 | 2005 | 145 | 0.060 |
Why?
|
Smad3 Protein | 1 | 2005 | 166 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2881 | 0.060 |
Why?
|
Insulin | 2 | 2017 | 6602 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2011 | 946 | 0.060 |
Why?
|
3T3 Cells | 1 | 2006 | 1085 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3077 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2419 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2910 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1994 | 0.060 |
Why?
|
CHO Cells | 1 | 2006 | 1388 | 0.050 |
Why?
|
Caspases | 1 | 2006 | 879 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5036 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2015 | 16979 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1693 | 0.050 |
Why?
|
Aorta | 1 | 2010 | 2041 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11073 | 0.050 |
Why?
|
Cricetinae | 1 | 2006 | 2425 | 0.050 |
Why?
|
Cyclophosphamide | 1 | 2008 | 2218 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3963 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11902 | 0.050 |
Why?
|
Photochemotherapy | 1 | 2008 | 823 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2021 | 64651 | 0.050 |
Why?
|
Splenomegaly | 1 | 2002 | 189 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7219 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2016 | 12796 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2009 | 1886 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2002 | 621 | 0.050 |
Why?
|
Hypersensitivity, Delayed | 1 | 2002 | 490 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 22168 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3597 | 0.040 |
Why?
|
Lymphatic Diseases | 1 | 2002 | 320 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2012 | 3667 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12450 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3792 | 0.040 |
Why?
|
DNA, Antisense | 1 | 1998 | 44 | 0.040 |
Why?
|
Lipid A | 1 | 2018 | 70 | 0.040 |
Why?
|
Cell Line | 2 | 2006 | 15605 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20556 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18400 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39975 | 0.030 |
Why?
|
Jurkat Cells | 1 | 1998 | 740 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2012 | 3755 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20093 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10441 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6532 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1878 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10762 | 0.030 |
Why?
|
Influenza A virus | 1 | 2018 | 458 | 0.030 |
Why?
|
Zidovudine | 1 | 2017 | 624 | 0.030 |
Why?
|
Blood Pressure | 1 | 2010 | 8487 | 0.030 |
Why?
|
Phosphorylation | 1 | 2005 | 8320 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4174 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7532 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 80582 | 0.020 |
Why?
|
Prognosis | 1 | 2013 | 29620 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2016 | 1079 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15838 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74167 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2002 | 2163 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 756 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3509 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3395 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2016 | 1878 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3810 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9606 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4354 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8179 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2011 | 815 | 0.010 |
Why?
|
Tumor Burden | 1 | 2008 | 1890 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2017 | 4525 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23742 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4912 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12720 | 0.010 |
Why?
|